Senior Manager Program Senior Managers are the heart of our

DISCOVERY BEGINS
WITH
AGILENT TECHNOLOGIES
THE
INDUSTRY LEADING AND MOST
COMPREHENSIVE ANALYTICAL
PORTFOLIO
1
A G I L E N T AT A G L A N C E
REVENUE IN FY11
EMPLOYEES
PRESIDENT AND CEO
CUSTOMER LOCATIONS
MANUFACTURING AND
R&D LOCATIONS
NYSE
3
$6.6 billion (more than 70% generated outside the U.S.)
20,000
William P. (Bill) Sullivan
100+ countries
U.S., Europe, Asia Pacific
A
A G I L E N T AT A G L A N C E
Addressing critical measurement challenges
Electronic Measurement Group
• Wireless technologies
• Mobile phone R&D and manufacturing
• Aerospace/defense systems and maintenance
• Computer & industrial research & manufacturing
Chemical Analysis Group
• Food safety, quality
• Energy research, production
• Quality of air, water, soil
• Forensics, drugs of abuse
• Pharmaceutical research and manufacturing
• Academic and government research
Life Sciences Group
• Cancer diagnostics
• Cytogenetics research
• Genomics tools for molecular analysis
Diagnostics and Genomics Group
4
M AY 1 4 , 2 0 1 0 : A G I L E N T A C Q U I R E S V A R I A N I N C .
What Agilent gains:
• New technologies, more applications,
expanded markets
• Ability to provide more complete solutions
to our life science and chemical analysis
customers
• Opportunity to become LSCA market
leader, building on our undisputed
leadership in electronic measurement
• Opportunity to leverage our electronic and
bio-analytical measurement capability
across our expanded product portfolio
8
Combining the power of two
Silicon Valley pioneers
A H E R I TA G E
OF
I N N O VAT I O N : V A R I A N & A G I L E N T
“The acquisition will establish Agilent as a clear market leader
in analytical solutions and give us the talent and technology base
for creating unique new products and markets.”
- Bill Sullivan, President and CEO, Agilent Technologies
9
AGILENT
TO A C Q U I R E
D A KO
• Agilent has signed a definitive agreement with EQT
to acquire Dako, a cancer diagnostics company in
Denmark
• All-cash deal of $2.2 billion
• Largest in Agilent’s history
• Expected to be finalized within 60 days
• Dako will operate as an independent business
within Agilent
• Reports to Agilent CEO
• No changes to management structure, payroll,
facilities
• Dako keeps name, adds Agilent tagline
10
B I O A N A LY T I C A L P L AT F O R M S
AND
M ARKETS
Molecular labeling
Technology
NMR
X-Ray
Atomic Force
Microscopy
Array Scanner
Genomics
Proteomics
Metabolomics
Pharma R&D/QC
Environmental
Chemical
Energy
Food
QTOF MS/MS
TOF /MS
QQQ MS/MS
HPLC
GC/MS
DNA Arrays
QPCR
PCR-RFLP
BioAnalyzer
CE
Q-PCR Reagents
ICP/MS
Chip HPLC/MS
Lab Automation
16
Isidro Masana
Especialista Productos LC-CE-GC/MS
Agilent Technologies
División de Biociencia y Análisis Químico
Razones y Aportaciones
de la Biología Integrada
• Extrema complejidad y variabilidad de los procesos biológicos.
• La inhibición de una ruta metabólica es habitual que genere la activación de
otras vías alternativas.
• Mutaciones, defectos en la transcripción, modificaciones
postraduccionales,…..
• La Integración de datos experimentales de las diferentes
–ómicas permitirá validar los resultados experimentales a través de
una coherente interpretación biológica de los cambios de expresión
observados entre distintas las distintas poblaciones de individuos/
tratamientos/ enfermedades/…. comparadas en el estudio.
Página 18
Multi-omics Analysis
Modern -omics technologies yield “snapshots” of discrete parts of the biological process.
The value of looking only at results from individual disciplines is limited.
• The real biological story is in the relationships amongst the biological entities, rather
than the entities themselves.
• Interpretive value comes from integrating diverse measurements within their biological
context.
Agilent Technologies - una Compañía con una Fuerte
Inversión en España: +500 empleados en España
“International Agilent Bussiness
Center”
World Trade Center
Barcelona
Oficinas/Fábrica en: Barcelona, Málaga, Madrid, Bilbao.
Page 21
July 7th to 9th , 2010
WIN 2010 organization
Agenda
Miguel Viribay Sales Director Iberia LSG.
Page 22
Jaume Morales
Page 23
DISCOVERY BEGINS
WITH
AGILENT TECHNOLOGIES
THE
INDUSTRY LEADING AND MOST
COMPREHENSIVE ANALYTICAL
PORTFOLIO
24